Maverick Capital’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-214,559
| Closed | -$12.2M | – | 369 |
|
|
2022
Q2 | $12.2M | Sell |
214,559
-104,969
| -33% | -$5.98M | 0.3% | 48 |
|
|
2022
Q1 | $25.8M | Sell |
319,528
-68,646
| -18% | -$5.55M | 0.45% | 45 |
|
|
2021
Q4 | $78.7M | Sell |
388,174
-1,054
| -0.3% | -$214K | 0.89% | 25 |
|
|
2021
Q3 | $105M | Buy |
389,228
+5,156
| +1% | +$1.39M | 1.06% | 21 |
|
|
2021
Q2 | $98.9M | Sell |
384,072
-6,482
| -2% | -$1.67M | 0.93% | 22 |
|
|
2021
Q1 | $117M | Sell |
390,554
-53,154
| -12% | -$15.9M | 1.08% | 16 |
|
|
2020
Q4 | $113M | Buy |
443,708
+65,160
| +17% | +$16.6M | 1.81% | 21 |
|
|
2020
Q3 | $94.2M | Buy |
378,548
+32,772
| +9% | +$8.16M | 1.75% | 19 |
|
|
2020
Q2 | $120M | Buy |
345,776
+19,216
| +6% | +$6.68M | 2.53% | 13 |
|
|
2020
Q1 | $87.4M | Buy |
326,560
+110,478
| +51% | +$29.6M | 1.85% | 15 |
|
|
2019
Q4 | $70M | Buy |
+216,082
| New | +$70M | 1.02% | 22 |
|